Demographics | SG (n = 44) | UG (n = 10) | t/χ2 | p | |
---|---|---|---|---|---|
Sex | Male | 31 | 6 | 0.413 | 0.521 |
Female | 13 | 4 | |||
Age at presentation, mean ± SD (d) | 72.4 ± 85.4 | 37.5 ± 25.5 | 1.273 | 0.209 | |
Weight at presentation, mean ± SD (kg) | 4.3 ± 1.4 | 4.3 ± 0.9 | 0.066 | 0.948 | |
PVO | 45.5% (20/44) | 60% (6/10) | 0.927 | 0.485 | |
gestational age(w) | 38.3 ± 2.31 | 39.40 ± 1.26 | −1.451 | 0.153 | |
the flow of PVO(m/s) | 2.52 ± 0.24 | 2.45 ± 0.23 | 0.679 | 0.504 | |
Preoperative Lowest pH | 7.22 ± 0.11 | 7.15 ± 0.13 | 1.923 | 0.06 | |
Preoperative Highest plasma lactate (mmol/L) | 2.21 ± 2.56 | 1.77 ± 0.80 | 0.533 | 0.596 | |
Preoperative AST | 78.09 ± 10.84 | 90.43 ± 100.64 | −0.33 | 0.740 | |
Preoperative Peak creatinine (μmol/L) | 40.37 ± 16.89 | 33.31 ± 10.48 | 1.262 | 0.213 | |
Preoperative Peak urea (mg/dl) | 4.29 ± 2.47 | 3.59 ± 2.37 | 0.924 | 0.360 | |
TAPVC type | Supracardiac | 23 | 3 | 4.123 | 0.248 |
Cardiac | 15 | 4 | |||
Infracardiac | 4 | 3 | |||
Mixed | 2 | 0 |